SMOC1 and central nervous system cancer: Consistent with the analysis of the TCGA datasets in GEPIA2, the survival analysis of CGGA datasets also showed a significant positive correlation between SMOC1 expression and better prognosis in all WHO grade I, WHO grade II, and WHO grade III gliomas but not in WHO grade IV glioma.